We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

32 hedge funds and large institutions have $66.9M invested in Fibrocell Science Inc. in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less capital invested

Capital invested by funds: $76.6M → $66.9M (-$9.71M)

16% less funds holding

Funds holding: 3832 (-6)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
4
Reduced
7
Closed
11
Calls
Puts
Net Calls
Net Calls Change

FCSC Hedge Fund Activity: Q4 2014 in Review

32 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2014, worth a combined $66.9M — down 13% from $76.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FCSC and 6 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Stoneridge Investment Partners, adding an estimated $130K. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $601K sold.

  • 32 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2014, down from 38 in Q3 2014.
  • Funds reported $66.9M of Fibrocell Science Inc. stock for Q4 2014, down 13% quarter-over-quarter.
  • 6 funds opened new Fibrocell Science Inc. positions in Q4 2014 and 11 closed out, a net change of -5 holders.
  • The largest Fibrocell Science Inc. buyer in Q4 2014 was Stoneridge Investment Partners, an estimated $130K added.
  • The largest Fibrocell Science Inc. seller in Q4 2014 was Cambridge Investment Research Advisors, an estimated $601K sold.

Based on aggregated 13F filings for Q4 2014.